Free Trial

Krilogy Financial LLC Buys 11,906 Shares of Danaher Corporation $DHR

Danaher logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Krilogy Financial more than doubled its Danaher position in the third quarter, purchasing 11,906 additional shares to hold 23,336 shares valued at approximately $5.17 million.
  • Institutional investors own 79.05% of Danaher, with major firms including BlackRock, Wellington Management, Jupiter Topco, Generation Investment Management and Bank of America holding significant positions.
  • Analyst sentiment remains positive, with Danaher carrying a “Moderate Buy” consensus rating and an average price target of $235.41. The company also exceeded quarterly earnings and revenue expectations and announced a $0.40-per-share dividend.
  • Five stocks we like better than Danaher.

Krilogy Financial LLC lifted its position in Danaher Corporation (NYSE:DHR - Free Report) by 104.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,336 shares of the conglomerate's stock after buying an additional 11,906 shares during the period. Krilogy Financial LLC's holdings in Danaher were worth $5,170,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of DHR. BlackRock Inc. bought a new stake in Danaher during the second quarter valued at approximately $10,492,520,000. Wellington Management Group LLP raised its stake in shares of Danaher by 10.4% in the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate's stock worth $3,108,031,000 after buying an additional 1,542,310 shares during the period. Jupiter Topco LLC bought a new position in shares of Danaher during the 2nd quarter valued at approximately $1,456,317,000. Generation Investment Management LLP purchased a new position in Danaher during the second quarter valued at approximately $1,287,949,000. Finally, Bank of America Corp DE bought a new position in shares of Danaher in the second quarter worth approximately $993,846,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Barclays lifted their target price on Danaher from $230.00 to $255.00 and gave the company an "overweight" rating in a research note on Wednesday, October 7th. Royal Bank Of Canada lifted their target price on Danaher from $215.00 to $250.00 and gave the stock an "outperform" rating in a report on Monday, October 5th. Morgan Stanley raised their target price on shares of Danaher from $220.00 to $240.00 and gave the company an "overweight" rating in a report on Monday. UBS Group started coverage on shares of Danaher in a research note on Wednesday, September 9th. They issued a "buy" rating and a $250.00 price objective for the company. Finally, Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research report on Saturday. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $235.41.

View Our Latest Research Report on Danaher

Danaher Trading Up 0.9%

Danaher stock opened at $223.30 on Wednesday. The stock has a market cap of $156.98 billion, a PE ratio of 39.66, a price-to-earnings-growth ratio of 2.78 and a beta of 0.76. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock has a 50-day moving average of $212.41 and a two-hundred day moving average of $195.13. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period in the previous year, the company earned $0.77 earnings per share. The business's quarterly revenue was up 5.5% compared to the same quarter last year. On average, research analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher's dividend payout ratio (DPR) is 28.42%.

About Danaher

(Free Report)

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines